Am Heart J

1. HANIF M, Khan LA, Kulkarni A, Bhatia HS, et al
   Global lipoprotein (a) testing trends from 2015 to 2023.
   Am Heart J. 2025 Jun 21:S0002-8703(25)00199-1. doi: 10.1016/j.ahj.2025.
   

   >> Share

   
   
2. DEVASENAPATHY N, Biswas S, Kini P, Satheesh S, et al
   Digoxin in rheumatic heart disease: Rationale and design of a multicenter, placebo-controlled double-blind randomized controlled trial (Dig-RHD trial).
   Am Heart J. 2025;289:38-47.
   

   >> Share

   
   

   
   Ann Thorac Surg

3. PHILIP J, Jacobs JP, Peek GJ, Stukov Y, et al
   100 Episodes of Support With Berlin Heart: Comparison of Patients Who Underwent Ventricular Assist Device Explantation After Cardiac Recovery With Those Without Cardiac Recovery.
   Ann Thorac Surg. 2025;120:374-382.
   

   >> Share

   
   

   
   Circ Cardiovasc Imaging

4. HIJAZI W, Shanbhag A, Miller RJH, Slomka PJ, et al
   Response by Hijazi et al to Letter Regarding Article, "Deep Learning-Derived Cardiac Chamber Volumes and Mass From PET/CT Attenuation Scans: Associations With Myocardial Flow Reserve and Heart Failure".
   Circ Cardiovasc Imaging. 2025 Jul 29:e018683.
   

   >> Share

   
   

   
   Circ Heart Fail

5. CAREY MR, Givertz MM
   There's No Place Like Home: Using Ambulatory Invasive Hemodynamic Monitoring to Facilitate Early Discharge From Heart Failure Hospitalization.
   Circ Heart Fail. 2025 Jul 31:e013274. doi: 10.1161/CIRCHEARTFAILURE.125.013274.
   

   >> Share

   
   

   
   Circ Res

6. PERALTA TM, Zelarayan LC
   Dot1L-H3K79me2-Tbx6 Axis: A Novel Therapeutic Target for Preventing Cardiac Failure.
   Circ Res. 2025;137:513-515.
   

   >> Share

   
   

   
   Circulation

7. PERGOLA V, Trancuccio A, Kukavica D, Mazzanti A, et al
   Genotype-Specific Outcomes of Desmosomal Cardiomyopathies.
   Circulation. 2025;152:233-245.
   

   >> Share

   
   
8. WANG Q, Ismahil MA, Zhu Y, Rokosh G, et al
   CD206(+)IL-4Ralpha(+) Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.
   Circulation. 2025;152:257-273.
   

   >> Share

   
   

   
   Clin Cardiol

9. REHMAN AU, Rayyan SM, Khan A
   Revisiting the Boundaries of GDMT Optimization: Beyond Adverse Effects and Into the Future of Personalized Heart Failure Care.
   Clin Cardiol. 2025;48:e70187.
   

   >> Share

   
   

   
   Eur Heart J

10. ADAMO M, Pagnesi M, Ajmone Marsan N, Bauersachs J, et al
    Heart failure with reduced ejection fraction and ventricular secondary mitral regurgitation: a holistic approach.
    Eur Heart J. 2025 Aug 1:ehaf480. doi: 10.1093.
    

    >> Share

    
    
11. KOBAYASHI M, Bayes-Genis A, Duarte K, McMurray JJV, et al
    Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction.
    Eur Heart J. 2025 Jul 30:ehaf457. doi: 10.1093.
    

    >> Share

    
    

    
    Eur J Heart Fail

12. KAUFMANN CC, Ahmed A, Harbich PF, Auer L, et al
    Prognostic impact of frailty at admission and in-hospital changes of frailty status in elderly patients with acute heart failure.
    Eur J Heart Fail. 2025 Jul 25. doi: 10.1002/ejhf.3779.
    

    >> Share

    
    
13. NASSIRI S, Voordes GHD, van Heerebeek L, van Raalte DH, et al
    Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo-controlled, crossover trial.
    Eur J Heart Fail. 2025 Jul 28. doi: 10.1002/ejhf.3711.
    

    >> Share

    
    
14. BAUMEIER C, Starlinger J, Aleshcheva G, Wiegleb G, et al
    Improved risk assessment in parvovirus B19-positive patients with heart failure by multiparametric analysis of endomyocardial biopsy using machine learning methods.
    Eur J Heart Fail. 2025 Jul 28. doi: 10.1002/ejhf.3798.
    

    >> Share

    
    
15. KUNZ M, Schulz M, Mahfoud F
    Reply to 'Expanding the horizon of medication adherence strategies in acutely decompensated heart failure'.
    Eur J Heart Fail. 2025 Jul 29. doi: 10.1002/ejhf.3803.
    

    >> Share

    
    
16. SUN R, Kong D, Jiang T
    Expanding the horizon of medication adherence strategies in acutely decompensated heart failure. Letter regarding the article 'Medication adherence in patients with acutely decompensated heart failure: A cross-sectional study in the emergency departme
    Eur J Heart Fail. 2025 Jul 29. doi: 10.1002/ejhf.3805.
    

    >> Share

    
    
17. KARAKAS M, Friede T, Butler J, Talha KM, et al
    Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes.
    Eur J Heart Fail. 2025 Jul 31. doi: 10.1002/ejhf.3742.
    

    >> Share

    
    

    
    Int J Cardiol

18. LANG Z, Girerd N, Zhang H, Xu H, et al
    Validation of a noninvasive device for measuring filling pressure against invasive pulmonary capillary wedge pressure.
    Int J Cardiol. 2025;438:133479.
    

    >> Share

    
    
19. ZAMORANO JL, Voros G, Calvi V, Osca J, et al
    Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trial.
    Int J Cardiol. 2025;438:133526.
    

    >> Share

    
    
20. TAKAGI R, Kobayashi M, Kuwahara A, Takihara K, et al
    Trajectory, correlates, and outcomes of pulmonary congestion by lung ultrasound in patients hospitalized for acute pulmonary edema.
    Int J Cardiol. 2025;438:133599.
    

    >> Share

    
    
21. DONG C, Cui Y, Sima M, Yue D, et al
    Letter regarding the study by Kuhn et al. on BMI and heart failure readmission risk: Rethinking obesity assessment.
    Int J Cardiol. 2025;439:133656.
    

    >> Share

    
    
22. YADAV A, Yadav O, Gupta N, Gupta R, et al
    Comments: Heart failure monitoring with a single?lead electrocardiogram at home.
    Int J Cardiol. 2025;439:133659.
    

    >> Share

    
    
23. SCHUPP T, Akin I, Behnes M
    Response to Letter by Dong et al.: BMI and heart failure readmission risk: Rethinking obesity assessment.
    Int J Cardiol. 2025;439:133673.
    

    >> Share

    
    

    
    J Am Coll Cardiol

24. WALLACE N, Wong K, Desmarais T, Park JJ, et al
    Optimizing the Primary Prevention of Sudden Cardiac Death in Patients With Heart Failure.
    J Am Coll Cardiol. 2025;86:374-395.
    

    >> Share

    
    
25. FIORETTI F, Testani JM, Tio MC, Pitt B, et al
    Aldosterone and Aldosterone Modulation in Cardio-Kidney Diseases.
    J Am Coll Cardiol. 2025;86:354-373.
    

    >> Share

    
    
26. MIN KH, Go AS, Lee K, Parikh RV, et al
    Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction.
    J Am Coll Cardiol. 2025;86:338-350.
    

    >> Share

    
    
27. VADUGANATHAN M, Neuen BL
    Combining SGLT2i and MRAs in Heart Failure: Playing the Long Game.
    J Am Coll Cardiol. 2025;86:334-337.
    

    >> Share

    
    
28. FERREIRA JP, Vasques-Novoa F, Saraiva F, Oliveira AC, et al
    Sodium-Glucose Cotransporter 2 Inhibitor With and Without an Aldosterone Antagonist for Heart Failure With Preserved Ejection Fraction: The SOGALDI-PEF Trial.
    J Am Coll Cardiol. 2025;86:320-333.
    

    >> Share

    
    
29. KRUMHOLZ HM
    Heart Failure in Practice: What and How.
    J Am Coll Cardiol. 2025;86:317-319.
    

    >> Share

    
    

    
    J Cardiol

30. NAGAI S, Kondo T, Morimoto R, Hiraiwa H, et al
    Association of Trace Element Abnormalities and Adverse Outcomes in Patients with Acute Heart Failure.
    J Cardiol. 2025 Jul 25:S0914-5087(25)00193-5. doi: 10.1016/j.jjcc.2025.
    

    >> Share

    
    

    
    PLoS One

31. PARK J, Park CS, Rhee TM, Choi HJ, et al
    On-treatment blood pressure and dose-dependent effects of ARNI in heart failure with reduced ejection fraction: Insights from a multicenter registry.
    PLoS One. 2025;20:e0328971.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share